Thank you to our Sponsors & Donors
interested in becoming one too?
The work of M4RD relies on the generous contributions of sponsors and donors.
In 2013, Students4RareDiseases (our original name) was grateful to receive funding from Sanofi Genzyme by working with The UK LSD Collaborative. They received the PAL Award for the project “Hear hooves…Think Zebra” and thanks to this award we transformed a small student society into a national organisation. Since then M4RD has received sponsorship and donations from different companies.
Find out more about what M4RD is doing to help make a difference here
We would like to thank all our sponsors and donors for their generous support. Rather than targeting resources on one specific disease they understand that one part of achieving earlier diagnoses is by breaking down the stigma of rare diseases in healthcare. The work of M4RD will benefit all rare diseases.
Find out about the exciting benefits M4RD will provide if you become a Corporate Partner and join us on our journey in driving an attitude change towards rare diseases #daretothinkrare
Please contact Jo McPherson to find out about M4RD’s 2024 work programme and to discuss how you can support M4RD with its mission.
If you would like to be a part of this change, please get in touch.
2024 Sponsors & Donors
2023
Alexion
Alnylam (Donation)
Amicus
BioCryst
Bionical Emas (Charity of Year)
Emotive
Chiesi (Donation)
Gilead
Kyowa Kirin
Orchard Therapeutics
PTC Therapeutics
Sanofi
SOBI
Takeda (Donation)
UCB
2022
Alexion
Amicus
BioMarin
Bionical Emas
Chiesi (Donation)
Emotive
Healx
Kyowa Kirin
Novartis (Donation)
Orchard Therapeutics
PTC Therapeutics
Sanofi
SOBI
Takeda (Donation)
2021
Alexion
Amicus Therapeutics
BioMarin
Bionical Emas
Emotive
Freeline
Illumina Corporate Foundation
PTC Therapeutics
Sarepta Therapeutics
SOBI
Takeda (Donation)
2020
Alexion
Amicus
BioMarin (Donation)
Emotive
Sanofi
SOBI
Takeda (Donation)
Ultragenyx (Donation)
2019
BioMarin
Inventiva
SOBI
2018
BioMarin
Inventiva
SOBI
Ultragenyx
Charitable Grants
Thank you to the following Charitable Trusts and Foundations for their support:
The Forrester Family Trust (2023)
The Grace Trust (2022)
The Hamamelis Trust (2024)
James Tudor Foundation (2022)
The Kenneth Hargreaves Charitable Trust (2023)
The Newby Trust (2023)
The RKT Charitable Trust (2023)
The Souter Charitable Trust (2022 & 2024)
All funding received is used for achieving the objects of Medics4RareDiseases. M4RD seeks funding from commercial companies with an interest in rare disease including pharmaceutical companies.
The interaction between pharmaceutical companies and patient organisations is regulated by the Association of the British Pharmaceutical Industry’s Code of practice (ABPI Code) in order to protect the public. The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner. Medics4RareDiseases is committed to ensuring its activities and partnerships are compliant with the code. Please take time to find out more here.
M4RD does not endorse any companies or products. M4RD is operated independently from these companies and they have no editorial control over M4RD’s content or activities. M4RD’s mission is in raising awareness and any information on this website does not constitute medical advice.